Hosted on MSN1mon
Paragon 28 stock rating cut to Equal Weight by Stephensreflects the potential for further financial benefit to Paragon 28's shareholders if the company meets the specified revenue targets post-acquisition. The transaction is a significant move for ...
Arizona State Retirement System decreased its position in shares of Paragon 28, Inc. (NYSE:FNA – Free Report) by 8.6% in the fourth quarter, HoldingsChannel reports. The firm owned 10,911 shares of ...
NEW YORK, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Hosted on MSN1mon
Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength?Zimmer Biomet agreed to buy Paragon 28 for an equity value of approximately $1.1 billion. The deal is expected to close in the first half of 2025. This company is expected to post quarterly loss ...
Paragon 2 (FNA) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976in connection with the previously announced acquisition of Paragon 28 ...
Paragon 28 (NYSE:FNA – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($ ...
The Ademi Firm is investigating Paragon 28 (NYSE: FNA) for possible breaches of fiduciary duty and other violations of law in its transaction with Zimmer Biomet. Click here to learn how to join ...
ENGLEWOOD, Colo., March 07, 2025--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to ...
Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year. Zimmer, a medical ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSE: FNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in ...
Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results